Adam Albitar

414 total citations
8 papers, 278 citations indexed

About

Adam Albitar is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Adam Albitar has authored 8 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Adam Albitar's work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Adam Albitar is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Adam Albitar collaborates with scholars based in United States and India. Adam Albitar's co-authors include Maher Albitar, Mohammed Farooqui, Adrian Wiestner, Inhye E. Ahn, Laura Wake, Constance M. Yuan, Susan Soto, Janet Valdez, Pia Nierman and Mark Raffeld and has published in prestigious journals such as Blood, Journal of Cellular Biochemistry and Oncotarget.

In The Last Decade

Adam Albitar

8 papers receiving 272 citations

Peers

Adam Albitar

GENET

PFM

IMMUN

MB

HEMAT

Laura Wake United States

Grégory Lazarian France

Anna Puiggros Spain

Kimberly J. Stockero United States

Federico Pozzo Italy

Rose Mantel United States

Rosella Famà Italy

Elisa Tammiso Italy

A Dattilo Italy

Ewa Wąsik‐Szczepanek Poland

Laura Wake United States

Adam Albitar

221 ×0.9

GENET

186 ×1.0

PFM

102 ×1.0

IMMUN

38 ×0.7

MB

51 ×1.0

HEMAT

Citations per year, relative to Adam Albitar Adam Albitar (= 1×) peers Laura Wake

Countries citing papers authored by Adam Albitar

Since Specialization

Citations

This map shows the geographic impact of Adam Albitar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Albitar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Albitar more than expected).

Fields of papers citing papers by Adam Albitar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Albitar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Albitar. The network helps show where Adam Albitar may publish in the future.

Co-authorship network of co-authors of Adam Albitar

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Albitar. A scholar is included among the top collaborators of Adam Albitar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Albitar. Adam Albitar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Albitar, Adam, Wanlong Ma, & Maher Albitar. (2017). Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations. Journal of Visualized Experiments. 4 indexed citations

2.

Albitar, Adam, et al.. (2017). Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations. Journal of Visualized Experiments. 1 indexed citations

3.

Albitar, Adam, et al.. (2017). The Application of CRISPR/Cas Technology to Efficiently Model Complex Cancer Genomes in Stem Cells. Journal of Cellular Biochemistry. 119(1). 134–140. 11 indexed citations

4.

Albitar, Adam, Wanlong Ma, Inhye E. Ahn, et al.. (2017). Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors. Oncotarget. 8(11). 17936–17944. 19 indexed citations

5.

Ahn, Inhye E., Chingiz Underbayev, Adam Albitar, et al.. (2017). Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia. Blood. 129(11). 1469–1479. 229 indexed citations

6.

Albitar, Adam, Danielle Townsley, Wanlong Ma, et al.. (2016). Higher Mutation Rate in Patients with Aplastic Anemia Using Peripheral Blood cfDNA As Compared with Bone Marrow Cells. Blood. 128(22). 3902–3902. 1 indexed citations

7.

Albitar, Adam, et al.. (2016). Positive selection and high sensitivity test for MYD88 mutations using locked nucleic acid. International Journal of Laboratory Hematology. 38(2). 133–140. 8 indexed citations

8.

Albitar, Adam, et al.. (2015). High Sensitivity Testing Shows Multiclonal Mutations in Patients with CLL Treated with BTK Inhibitor and Lack of Mutations in Ibrutinib-Naive Patients. Blood. 126(23). 716–716. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact